A recent report published by Infinium Global Research on H1N1 vaccines market provides in-depth analysis of segments and sub-segments in global as well as regional H1N1 vaccines market. The study also highlights the impact of drivers, restraints and macro indicators on the global and regional H1N1 vaccines market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global H1N1 vaccines market. According to the report the global H1N1 vaccines market is projected to grow at a CAGR of 5.2% over the forecast period of 2018-2024.
H1N1 virus or swine flu is an infectious disease in humans caused by the swine H1N1 virus. H1N1 virus affects various species such as birds, swine, horses and other animals. When a person is infected with this virus, it causes damage to the respiratory system including nose, lungs, and throat. This virus is contagious and can spread from human to human.
The H1N1 virus is a ribonucleic acid virus belonging to the Orthomyxoviridae family. Influenza viruses can be categorized on the basis of antigenicity of its surface glycoproteins neuraminidase and hemagglutinin. The virus used hemagglutinin element to bind to host cell receptors. This simplifies viral entry into the host cell. Neuraminidase protein enzymatically slices terminal sialic acid, which is present in mucins, thereby allowing the virus to reach underlying cells in the respiratory tract. Individuals with medical conditions such as blood disorders, asthma, kidney disorders, liver disorders, chronic lung disease, and neurodevelopmental and neurological conditions are at a high risk of being infected with this virus.
The rising incidences of swine flu, the need for H1N1 vaccination is increasing worldwide. The antivirals are given to an individual through a vaccine to prevent or reduce the effect of the virus. Additionally, the risk of respiratory diseases and immune deficient diseases is increased among the geriatric population; thus increasing the risk factor for acquiring H1N1 influenza. Moreover, advancement in vaccine technologies has increased research in this field and substantial government support are likely to drive the growth of the market. On the other hand, lack of skilled medical professionals to and lack of alertness are the factors hampering the growth of the market.
Among the geographies, North America is expected to be the largest market for H1N1 vaccine followed by Europe due to the presence of developed research organization in this region. While, Asia-Pacific is expected to grow fast during the forecast period, owing to the increasing awareness about the diseases, rising cases of this infection and growing government support in countries like China and India is likely to augment the growth in this region. Collaborations and mergers between manufacturing companies and government associations to maintain their presence in the world market and new product launches are the key strategies of the leading player in this market.
The report on global H1N1 vaccines market covers segments such as route of administration. On the basis of route of administration the global H1N1 vaccines market is categorized into intranasal vaccines, intradermal vaccines, and intramuscular vaccines.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section, the key trends and market size for each geography are provided over the period of 2015-2024.
The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience growth at a CAGR of x.x% over the period of 2018-2024.
The report provides profiles of the companies in the global H1N1 vaccines market such as Abbott, Baxter International, Sanofi, GSK, Pfizer, Mitsubishi Tanabe Pharma, Hualan Biological Engineering, Cipla, Merck, and Sinovac Biotech.
The report provides deep insights on demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the global H1N1 vaccines market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of H1N1 vaccines market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the H1N1 vaccines market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players. This report will help manufacturers, suppliers, and distributors of the H1N1 vaccines market to understand the present and future trends in this market and formulate their strategies accordingly.